Does MEPOLIZUMAB Cause C-reactive protein increased? 610 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 610 reports of C-reactive protein increased have been filed in association with MEPOLIZUMAB (Nucala). This represents 1.4% of all adverse event reports for MEPOLIZUMAB.
610
Reports of C-reactive protein increased with MEPOLIZUMAB
1.4%
of all MEPOLIZUMAB reports
557
Deaths
491
Hospitalizations
How Dangerous Is C-reactive protein increased From MEPOLIZUMAB?
Of the 610 reports, 557 (91.3%) resulted in death, 491 (80.5%) required hospitalization, and 486 (79.7%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 610 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which MEPOLIZUMAB Alternatives Have Lower C-reactive protein increased Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE